Featured Research

from universities, journals, and other organizations

Breast cancer cells' sugar craving is target for new type of treatment

Date:
July 31, 2013
Source:
University of Southampton
Summary:
A new way to target a breast cancer cells’ appetite for over-indulging in sugar, that could provide an alternative treatment for chemotherapy resistant breast cancer is being developed.

A dividing cancer cell.
Credit: Image courtesy of University of Southampton

A new way to target a breast cancer cells' appetite for over-indulging in sugar, that could provide an alternative treatment for chemotherapy resistant breast cancer, is being developed by Breast Cancer Campaign scientists at the University of Southampton.

The treatment exploits a novel link, identified by the scientists, between sugar processing in the cells and their growth and division.

This approach to treating breast cancer offers a real alternative to chemotherapy as it targets the active cancer cells and not normal cells, reducing the risk of side effects that affect thousands of women undergoing treatment.

Breast Cancer Campaign funded scientist, Dr Jeremy Blaydes at the University of Southampton, has shown for the first time that chemicals called cyclic peptide inhibitors can stop 'sweet toothed' cancer cells from growing and multiplying by blocking proteins in the cells called CtBPs (C-terminal binding proteins).

A key feature of cancer cells is they gorge on sugar from the blood, greedily processing it as a fuel supply which triggers CtBPs to bind together, forming pairs known as dimers that enable cells to grow and multiply out of control.

In unique laboratory experiments, Dr Jeremy Blaydes and colleagues developed a number of chemicals designed to block CtBP dimers from forming. They then selected the most effective chemical, CP61, which they are now developing in the lab for use as a breast cancer treatment.

Dr Blaydes comments: "Because this is an entirely new approach to treatment, the drugs we are developing could be effective against breast cancers that have become resistant to current chemotherapies. Unfortunately, despite great improvements in breast cancer treatment in recent years, chemotherapy-resistance eventually happens in around one in five cases (20 per cent), and every year in the UK around 12,000 women still die from the disease. To overcome this resistance, innovative treatments that use new approaches to stop cancer from growing are desperately needed.

"What makes this discovery even more exciting as a potential treatment is that CtBPs are mostly only active in the cancer cells, so blocking this 'sweet tooth' should cause less damage to normal cells and fewer side effects than existing treatments.

"This work is at an early stage in the laboratory but it is really exciting as it has the potential to deliver a completely new kind of cancer drug, which could be available within 10 years."

Dr Stuart Griffiths, Director of Research at Breast Cancer Campaign, adds: "For women whose breast cancer has become resistant to chemotherapy, this potential new treatment could offer a much needed life line.

"In 2003 Dr Blaydes' pioneering CtBP research was identified by Breast Cancer Campaign as a project with huge potential to save and improve lives. Continuous investment in this research has brought us to the brink of a potential new treatment for people who desperately need an alternative to chemotherapy in order to increase their chance of survival.

"Every year, thousands of women still die and millions are affected by breast cancer so we will continue to seek out world-class research, bringing the brightest minds together to share knowledge and produce better, quicker results. Because we passionately believe we owe it to every woman affected by this disease to explore every avenue to overcome and outlive breast cancer -- in our lifetime."

This project was partly funded through Breast Cancer Campaign's partnership with Asda and it's Tickled Pink campaign, Debenhams Think Pink campaign and The Generations Walk.

The findings were published in the August issue of Chemical Science.


Story Source:

The above story is based on materials provided by University of Southampton. Note: Materials may be edited for content and length.


Journal Reference:

  1. Charles N. Birts, Sharandip K. Nijjar, Charlotte A. Mardle, Franciane Hoakwie, Patrick J. Duriez, Jeremy P. Blaydes, Ali Tavassoli. A cyclic peptide inhibitor of C-terminal binding protein dimerization links metabolism with mitotic fidelity in breast cancer cells. Chemical Science, 2013; 4 (8): 3046 DOI: 10.1039/c3sc50481f

Cite This Page:

University of Southampton. "Breast cancer cells' sugar craving is target for new type of treatment." ScienceDaily. ScienceDaily, 31 July 2013. <www.sciencedaily.com/releases/2013/07/130731230014.htm>.
University of Southampton. (2013, July 31). Breast cancer cells' sugar craving is target for new type of treatment. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2013/07/130731230014.htm
University of Southampton. "Breast cancer cells' sugar craving is target for new type of treatment." ScienceDaily. www.sciencedaily.com/releases/2013/07/130731230014.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

AFP (Sep. 16, 2014) Since the arrival of Ebola in Ivory Coast, Ivorians have been abandoning their pets, particularly monkeys, in the fear that they may transmit the virus. Duration: 00:47 Video provided by AFP
Powered by NewsLook.com
Study Links Male-Pattern Baldness To Prostate Cancer

Study Links Male-Pattern Baldness To Prostate Cancer

Newsy (Sep. 16, 2014) New findings suggest men with a certain type of baldness at age 45 are 39 percent more likely to develop aggressive prostate cancer. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins